Palliative and End-of-Life Care in Hematologic Malignancies: Progress and Opportunities.
Publication
, Journal Article
Tsang, M; LeBlanc, TW
Published in: JCO Oncol Pract
June 2024
@JCOOP_ASCO editorial on unique needs of end-of-life care for different blood cancers discusses: #pallheme improves QOL but less utilized in cancers. Contextualize Weisse et al study. More #pallheme research needed for lymphoma and myeloma in era of cell therapy.
Duke Scholars
Published In
JCO Oncol Pract
DOI
EISSN
2688-1535
Publication Date
June 2024
Volume
20
Issue
6
Start / End Page
739 / 741
Location
United States
Related Subject Headings
- Terminal Care
- Quality of Life
- Palliative Care
- Humans
- Hematologic Neoplasms
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Tsang, M., & LeBlanc, T. W. (2024). Palliative and End-of-Life Care in Hematologic Malignancies: Progress and Opportunities. JCO Oncol Pract, 20(6), 739–741. https://doi.org/10.1200/OP.24.00081
Tsang, Mazie, and Thomas W. LeBlanc. “Palliative and End-of-Life Care in Hematologic Malignancies: Progress and Opportunities.” JCO Oncol Pract 20, no. 6 (June 2024): 739–41. https://doi.org/10.1200/OP.24.00081.
Tsang M, LeBlanc TW. Palliative and End-of-Life Care in Hematologic Malignancies: Progress and Opportunities. JCO Oncol Pract. 2024 Jun;20(6):739–41.
Tsang, Mazie, and Thomas W. LeBlanc. “Palliative and End-of-Life Care in Hematologic Malignancies: Progress and Opportunities.” JCO Oncol Pract, vol. 20, no. 6, June 2024, pp. 739–41. Pubmed, doi:10.1200/OP.24.00081.
Tsang M, LeBlanc TW. Palliative and End-of-Life Care in Hematologic Malignancies: Progress and Opportunities. JCO Oncol Pract. 2024 Jun;20(6):739–741.
Published In
JCO Oncol Pract
DOI
EISSN
2688-1535
Publication Date
June 2024
Volume
20
Issue
6
Start / End Page
739 / 741
Location
United States
Related Subject Headings
- Terminal Care
- Quality of Life
- Palliative Care
- Humans
- Hematologic Neoplasms
- 3211 Oncology and carcinogenesis